121487-12-5Relevant articles and documents
Delta opiate receptor antagonist, application thereof and medicine composition
-
Paragraph 0192-0195, (2019/07/04)
The invention discloses a compound with a structure shown as a general formula (I) (the general formula is shown in the description), a pharmaceutical salt, hydrate or metabolite formed through metabolism in any form, application of the compound with the
PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS
-
Page/Page column 74, (2015/10/05)
The present invention is directed to compounds of Formula I pharmaceutical compositions comprising the same, and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS.
One-pot etherification of purine nucleosides and pyrimidines
Kokatla, Hari Prasad,Lakshman, Mahesh K.
supporting information; experimental part, p. 4478 - 4481 (2010/12/24)
A one-pot synthesis of ethers derived from inosine, guanosine, 2′-deoxyguanosine, and pyrimidinones is described. Exposure of the heterocycle to 1H-benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP) and Cs2CO3/s